NURIX THERAPEUTICS INC. - COMMON STOCK

Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers

16 мар 2021 08:31:21 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Presentation of NX-1607 Preclinical Data at AACR

10 мар 2021 16:12:18 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

09 мар 2021 15:01:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics to Participate and Present at Upcoming Investor Conferences

09 мар 2021 06:30:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

04 мар 2021 19:01:29 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Launch of Proposed Public Offering of Common Stock

02 мар 2021 15:15:45 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update

16 фев 2021 15:01:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies

07 янв 2021 06:00:00 Источник Nasdaq GlobeNewswire